tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Takeda Pharmaceutical Co (JP:4502)
:4502
Japanese Market
4502
Takeda Pharmaceutical Co
RESEARCH TOOLSreports
Advertisement

Takeda Pharmaceutical Co (4502) Stock News & Sentiment

Compare
5 Followers
Takeda Announces Financial Reclassification to Enhance Capital Flexibility
Premium
Company Announcements
Takeda Announces Financial Reclassification to Enhance Capital Flexibility
5d ago
Promising Phase 3 Results for Takeda’s Oveporexton Boost Buy Rating
Premium
Ratings
Promising Phase 3 Results for Takeda’s Oveporexton Boost Buy Rating
21d ago
TAK
Takeda Pharmaceutical’s Promising Narcolepsy Treatment Drives Buy Rating
Premium
Ratings
Takeda Pharmaceutical’s Promising Narcolepsy Treatment Drives Buy Rating
21d ago
TAK
Takeda’s Oveporexton Shows Promise in Phase 3 Narcolepsy Trials
Premium
Company Announcements
Takeda’s Oveporexton Shows Promise in Phase 3 Narcolepsy Trials
22d ago
Takeda’s Narcolepsy Drug Study Abstract Accidentally Published
Premium
Company Announcements
Takeda’s Narcolepsy Drug Study Abstract Accidentally Published
2M ago
Takeda Pharmaceutical Reports Q1 2025 Earnings with Profit Growth
Premium
Company Announcements
Takeda Pharmaceutical Reports Q1 2025 Earnings with Profit Growth
2M ago
Takeda Pharmaceutical Reports Mixed Financial Results for Q2 2025
Premium
Company Announcements
Takeda Pharmaceutical Reports Mixed Financial Results for Q2 2025
2M ago
More JP:4502 News >

4502 News on the Web

Takeda Announces Financial Reclassification to Enhance Capital Flexibility
TipRanks News
Neutral
Morgan Stanley Reaffirms Their Buy Rating on Takeda Pharmaceutical Co (TKPHF)
TipRanks News
Neutral
FDA Approves Expanded Indication For Takeda's VONVENDI In Von Willebrand Disease
rttnews
Neutral
Nomura Keeps Their Buy Rating on Takeda Pharmaceutical Co (TKPHF)
TipRanks News
Neutral
Takeda and Protagonist Reveal Positive Phase 3 VERIFY Study Results
TipRanks News
Neutral
Takeda Proposes Re-election of Directors Ahead of Leadership Transition
TipRanks News
Neutral
The European Medicines Agency
Yahoo Finance
Neutral
Julie Kim Will Succeed Christophe Weber as CEO of Takeda in June 2026
Yahoo Finance
Neutral

News Score - Last 7 Days

Neutral
JP:4502
Sector Average
Media Buzz
This Week2 articles
Weekly Average1 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is JP:4502’s Media Buzz Sentiment?
2 articles about JP:4502 were published this week. In an average week, 1 articles are published.
    What is JP:4502’s weekly average amount of articles?
    In an average week, 1 articles about JP:4502 are published.
      What is JP:4502’s News Sentiment?
      50% of articles about JP:4502 were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        COLLCollegium Pharmaceutical
        ACADACADIA Pharmaceuticals
        VCYTVeracyte
        ARQTArcutis Biotherapeutics
        CDTXCidara Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week

        Become an Expert with TipRanks Premium

        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis
        Subscribe NowSee Plans & Pricing